WASHINGTON — America’s drug price debate is coming to the Supreme Court.
How the nation’s highest court rules in a case that, on its face, has nothing to do with prescription drugs could, nonetheless, leave a big mark on medicine. Oral arguments in the case, to be heard Monday, come as a huge majority of Americans say medicines are not affordable and drug costs have become a major issue in the 2016 presidential race.
Brand-name pharmaceutical manufacturers are warning that the wrong ruling could limit their ability to recoup their investment in research and development, putting their drug pipelines at risk.
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect